Clinical Trial Update: Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating apatinib for recurrence or metastasis of esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Esophageal Squamous Cell Carcinoma, Apatinib | Phase 2 | Status: UNKNOWN